Cutis. 2024 Aug;114(2):E15-E23. doi: 10.12788/cutis.1080.
ABSTRACT
Melasma is a chronic pigmentary disorder that results in hyperpigmented patches in sun-exposed areas. Tranexamic acid (TXA) and microneedling are potential treatment options for individuals with melasma. The objective of our systematic review was to review 12 randomized controlled trials and clinical trials on the use and efficacy of TXA with microneedling for melasma. The combination of TXA and microneedling was found to be more effective at improving melasma lesions than either treatment alone; TXA alone was equally effective at reducing melasma lesions vs the standard treatment of hydroquinone.
PMID:39298769 | DOI:10.12788/cutis.1080
Cureus. 2024 Oct 21;16(10):e72053. doi: 10.7759/cureus.72053. eCollection 2024 Oct. ABSTRACT This case study describes a severe and rare complication following the placement
Clin Breast Cancer. 2024 Oct 23:S1526-8209(24)00285-4. doi: 10.1016/j.clbc.2024.10.007. Online ahead of print. ABSTRACT OBJECTIVE: Literature regarding nonpharmacological interventions (NPI) for PMPS or
Arch Dermatol Res. 2024 Nov 13;317(1):13. doi: 10.1007/s00403-024-03449-4. ABSTRACT Melasma is an acquired dysfunction of melanogenesis, that poses a major therapeutic challenge
© Integrative Dry Needling 2023 | All rights reserved | Designed by Weblink
Powered by 
any IDN Course!
*This discount is valid for new registrations only and can not be combined with other discount codes. Offer Expires: 12/31/2023
Not sure which course is right for you? No problem – we created an intuitive process to help!
